Quality of life impact associated to melasma: Colombian experience
DOI:
https://doi.org/10.29176/2590843X.1897Keywords:
Melasma, Quality of life, Quality of life indicators, Chloasma, PigmentationAbstract
Background: Melasma is a very common and prevalent pigmentary disorder in women of high phototypes. It corresponds to a chronic and recurrent disease that considerably affects the quality of life of those who suffer it. The aim of this study was to evaluate the clinical features related to quality of life of patients diagnosed with melasma.
Materials and methods: Cross-sectional study, 50 patients of both genders with a melasma evaluated between april and may 2023. Sociodemographic and clinical features were analyzed, and the following scales were applied: Modified Melasma Area and Severity Index (mMASI), Dermatology Quality of Life Index (DLQI) and the Melasma Quality of Life Scale adapted and validated to Spanish (Sp-MelasQoL).
Results: The mean age was 42.28 years, 92% were women and 8% men. The mean of the total Sp-MelasQoL score was 39.46. Of these 84% of patients were bothered by the appearance of melasma, 66% felt frustrated, 60% embarrassed, 50% felt less attractive and 46% depressed. Additionally, there was statistical association between quality of life compromise and the variables mMASI, time of evolution and facial distribution of melasma.
Conclusions: A significant association was identified between melasma severity, duration and important emotional affectation in the patients evaluated. As dermatologists, this type of study highlights the importance of considering the emotional impact of this type of pathologies on our daily clinical practice.
Author Biographies
Criss Madeley Millán Puerto, Universidad Industrial de Santander, Bucaramanga, Colombia.
Médica general, Universidad Industrial de Santander, Bucaramanga, Colombia.
Cesar González Ardila, Clínica Privada de Dermatología, Bogotá, Colombia.
Director médico. Dermatólogo, Clínica Privada de Dermatología, Bogotá, Colombia.
Laura Trujillo Ramírez, Clínica Privada de Dermatología, Bogotá, Colombia.
Dermatóloga, Clínica Privada de Dermatología, Bogotá, Colombia.
Angie Julieth Holguin Molina, Universidad El Bosque, Bogotá, Colombia.
Estudiante de Medicina, Universidad El Bosque, Bogotá, Colombia.
References
Pollak DC, Alarcón MC, Fuentes I, Druck PA. Melasma en el 2021: actualización en la patogénesis y en el enfrentamiento terapéutico. Rev Chil Dermatol [Internet]. 1 de marzo de 2023 [citado 7 de noviembre de 2023];37(3). Disponible en: https://www.rcderm.org/index.php/rcderm/article/view/365
Ikino JK, Nunes DH, Silva VPM da, Fröde TS, Sens MM. Melasma and assessment of the quality of life in Brazilian women. An Bras Dermatol. 2015;90(2):196-200.
Nicolaidou E, Antoniou C, Katsambas AD. Origin, clinical presentation, and diagnosis of facial hypermelanoses. Dermatol Clin. julio de 2007;25(3):321-6, viii.
Espósito ACC, Cassiano DP, da Silva CN, Lima PB, Dias JAF, Hassun K, et al. Update on Melasma-Part I: Pathogenesis. Dermatol Ther. septiembre de 2022;12(9):1967-88.
Cassiano DP, Espósito ACC, da Silva CN, Lima PB, Dias JAF, Hassun K, et al. Update on Melasma—Part II: Treatment. Dermatol Ther. 1 de septiembre de 2022;12(9):1989-2012.
Espósito ACC, Souza NP de, Miot LDB, Miot HA. Deficit in autophagy: A possible mechanism involved in melanocyte hyperfunction in melasma. Indian J Dermatol Venereol Leprol. 30 de junio de 2021;87(4):585-6.
Espósito ACC, Brianezi G, de Souza NP, Santos DC, Miot LDB, Miot HA. Ultrastructural characterization of damage in the basement membrane of facial melasma. Arch Dermatol Res. 1 de abril de 2020;312(3):223-7.
Espósito ACC, Brianezi G, Miot LDB, Miot HA. Fibroblast morphology, growth rate and gene expression in facial melasma. An Bras Dermatol. 1 de septiembre de 2022;97(5):575-82.
Ogbechie-Godec OA, Elbuluk N. Melasma: an Up-to-Date Comprehensive Review. Dermatol Ther. septiembre de 2017;7(3):305-18.
Wang RF, Ko D, Friedman BJ, Lim HW, Mohammad TF. Disorders of hyperpigmentation. Part I. Pathogenesis and clinical features of common pigmentary disorders. J Am Acad Dermatol. 1 de febrero de 2023;88(2):271-88.
Morgado-Carrasco D, Piquero-Casals J, Granger C, Trullàs C, Passeron T. Melasma: The need for tailored photoprotection to improve clinical outcomes. Photodermatol Photoimmunol Photomed. 2022;38(6):515-21.
Balkrishnan R, Mcmichael AJ, Camacho FT, Saltzberg F, Housman TS, Grummer S, et al. Development and validation of a health‐related quality of life instrument for women with melasma. Br J Dermatol. 1 de septiembre de 2003;149(3):572-7.
Rodrigues M, Ayala-Cortés AS, Rodríguez-Arámbula A, Hynan LS, Pandya AG. Interpretability of the Modified Melasma Area and Severity Index (mMASI). JAMA Dermatol. 1 de septiembre de 2016;152(9):1051-2.
FINLAY AY, KHAN GK. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol. 1 de mayo de 1994;19(3):210-6.
Dominguez AR, Balkrishnan R, Ellzey AR, Pandya AG. Melasma in Latina patients: Cross-cultural adaptation and validation of a quality-of-life questionnaire in Spanish language. J Am Acad Dermatol. 1 de julio de 2006;55(1):59-66.
Cestari TF, Hexsel D, Viegas ML, Azulay L, Hassun K, Almeida ART, et al. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL‐BP study and improvement of QoL of melasma patients after triple combination therapy. Br J Dermatol. 1 de diciembre de 2006;156(s1):13-20.
Misery L, Schmitt AM, Boussetta S, Rahhali N, Taieb C. Melasma: Measure of the Impact on Quality of Life Using the French Version of MELASQOL after Cross-cultural Adaptation. Acta Derm Venereol. 22 de febrero de 2010;90(3):331-2.
Dogramaci AC, Havlucu DY, Inandi T, Balkrishnan R. Validation of a melasma quality of life questionnaire for the Turkish language: The MelasQoL-TR study. J Dermatol Treat. 1 de enero de 2009;20(2):95-9.
Miguel LMZ, Jorge MFS, Rocha B, Miot HA. Incidence of skin diseases diagnosed in a public institution: comparison between 2003 and 2014. An Bras Dermatol. junio de 2017;92(3):423-5.
Espósito MCC, Espósito ACC, Lemos FK, Jorge MFS, D’Elia MPB, Miot HA. Melasma: Trends in worldwide Internet searches (2000-2019). Indian J Dermatol Venereol Leprol. 2022;88(5):675-7.
Tamega A de. A, Miot L d. b., Bonfietti C, Gige T c., Marques M e. a., Miot H a. Clinical patterns and epidemiological characteristics of facial melasma in Brazilian women. J Eur Acad Dermatol Venereol. 2013;27(2):151-6.
Handel AC, Miot LDB, Miot HA. Melasma: a clinical and epidemiological review. An Bras Dermatol. octubre de 2014;89:771-82.
Ali R, Aman S, Nadeem M, Kazmi AH. Quality of life in patients of melasma. J Pak Assoc Dermatol. 2013;23(2):143-8.
Rivera Z, Rivera I, Ollarves V, Lugo D, Hagel I. Melasma en mujeres latinas. 1 de enero de 2020;21:142-50.
Guinot C, Cheffai S, Latreille J, Dhaoui M, Youssef S, Jaber K, et al. Aggravating factors for melasma: a prospective study in 197 Tunisian patients. J Eur Acad Dermatol Venereol. septiembre de 2010;24(9):1060-9.
Achar A, Rathi SK. MELASMA: A CLINICO-EPIDEMIOLOGICAL STUDY OF 312 CASES. Indian J Dermatol. 2011;56(4):380-2.
Rivera PXJ, Castillo DEM. Melasma y calidad de vida: estudio clínico prospectivo y descriptivo de 142 pacientes.Medicina cutánea ibero-latino-americana, ISSN 0210-5187, Vol. 46, Nº. 2, 2018, págs. 104-111
Purim KSM, Avelar MF de S. Fotoproteção, melasma e qualidade de vida em gestantes. Rev Bras Ginecol E Obstetrícia. mayo de 2012;34:228-34.
González Gómez LJ. Validación de la escala de calidad de vida MELASQoL, en un grupo de pacientes colombianas con melasma. 20 de diciembre de 2009 [citado 7 de noviembre de 2023]; Disponible en: http://repository.urosario.edu.co/handle/10336/1661
Uyanikoglu H, Aksoy M. Quality of life in patients with melasma in Turkish women. Dermatol Rep [Internet]. 11 de octubre de 2017 [citado 12 de noviembre de 2023];9(2). Disponible en: https://www.pagepress.org/journals/index.php/dr/article/view/7340
ASALE R, RAE. «Diccionario de la lengua española» - Edición del Tricentenario. [citado 7 de noviembre de 2023]. cloasma | Diccionario de la lengua española. Disponible en: https://dle.rae.es/cloasma
How to Cite
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
